Skip to main content
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. — Investor Relations & Filings

Ticker · PRAX ISIN · US74006W2070 US Manufacturing
Open in API
Filings indexed 458 across all filing types
Latest filing 2022-11-09 Earnings Release
Country US United States of America
Listing US PRAX

About Praxis Precision Medicines, Inc.

https://praxismedicines.com/

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company's methodology involves translating insights from genetic epilepsies into treatments for conditions characterized by neuronal excitation-inhibition imbalance. Praxis employs a genetics-focused approach, utilizing translational tools and patient-guided development strategies to advance its portfolio. The developmental pipeline includes several clinical-stage assets and numerous early-stage programs designed to address complex brain disorders.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated November 9, 2022, by Praxis Precision Medicines, Inc. It announces the company's financial results for the quarter ended September 30, 2022, and includes a press release and a corporate presentation as exhibits. The document explicitly states that the press release and presentation are furnished as exhibits and that the information is not "filed" for purposes of Section 18 of the Exchange Act, indicating this is an announcement rather than the full financial report itself. The length is 4052 characters, which is relatively short and consistent with an announcement rather than a full report. The content corresponds to an Earnings Release (ER) announcement and an Investor Presentation (IP) announcement, but since the main body focuses on announcing the financial results and furnishing the press release, the primary classification is Earnings Release (ER).
2022-11-09 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-10-11 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC by Praxis Precision Medicines, Inc. It reports recent events including FDA communications about clinical holds and IND applications related to clinical studies. The document is dated September 2, 2022, and contains no financial statements or detailed financial analysis. It is a regulatory announcement of material events rather than a full financial report or earnings release. The Form 8-K is a standard SEC filing used to disclose significant corporate events promptly. Therefore, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-09-07 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 10, 2022, by Praxis Precision Medicines, Inc. The key content is the resignation of a board member and appointment of new members to board committees. This is an announcement of changes in the company's board of directors. There are no financial statements or detailed financial data, so it is not an Annual Report or Interim Report. The document fits the category of Board/Management Information (MANG) as it announces changes in the board and senior management positions.
2022-08-12 English
10-Q
Interim / Quarterly Report Q2 2022
2022-08-08 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 8, 2022, by Praxis Precision Medicines, Inc. It includes an announcement of financial results for the quarter ended June 30, 2022, and a corporate presentation update. The document references a press release and a presentation as exhibits but does not contain detailed financial statements or comprehensive analysis itself. The content primarily serves as a regulatory filing to disclose recent events and updates rather than a full financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific report types.
2022-08-08 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.